Showing results (371-380 of 386) with videos related to

Sort By:
Pageof 39
Scientific Reports|July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasiaMichael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2024
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian MenLiang Dong, Katherine Lajkosz, Rafael Sanchez-Salas, et al.
European Urology|July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
JCO Precision Oncology|February 26, 2019
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate CancerEve O'Reilly, Alexandra V Tuzova, Anna L Walsh, et al.
Cancer Letters|November 7, 2022
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathwaysLouis Lacombe, Hélène Hovington, Hervé Brisson, et al.
European Urology|May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform SubpathologiesMelvin L K Chua, Winnie Lo, Melania Pintilie, et al.
Urologic Oncology|December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patientsLaura S Mertens, Francesco Claps, Roman Mayr, et al.
Nature|November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomesShu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Pageof 39